Vien Dong Pharmaceutical JSC
_________________________________________________________________________________
Vien Dong Pharmaceutical JSC Financial Snapshot
Operating Performance
Fast Facts
The company reported revenue of US$50.94 million
Headquarters Address No. 411, Phu Nhuan, ,Vietnam
during the fiscal year 2009 (2009), an increase of
32.28% over 2008. In 2009, the company recorded an
Telephone + 84 8 39910866
operating margin of 14.89%, as against 5.53% in
2008.
Fax + 84 8 39910867
Website N/A Revenue and Margins
Ticker Symbol, Stock Exchange DVD, Hochiminh Stock Exchange
Number of Employees 646
Fiscal Year End December
Revenue (in US$ million) 50.94
Revenue (in VND million) 917,186.31
Return on Equity
The company recorded a return on equity (ROE) of
25.39% for 2009, as compared to its peers, DHG
Pharmaceutical JSC (Ticker: DHG), Hatay
Pharmaceutical JSC (Ticker: DHT) and Imexpharm
Pharmaceutical JSC (Ticker: IMP), which recorded
ROEs of 35.07%, 16.48% and 12.22% respectively.
The company reported an operating margin of
14.89% in 2009.
Return on Equity
Liquidity Position
The company reported a current ratio of 2.02 in 2009,
as compared to its peers, DHG Pharmaceutical JSC,
Hatay Pharmaceutical JSC and Imexpharm
Pharmaceutical JSC, which recorded current ratios of
2.74, 1.34 and 2.88 respectively. As of December
2009, the company recorded cash and short-term
investments of worth US$5.67 million, against
US$0.01 million current debt. The company reported
a debt to equity ratio of 0.37 in 2009 as compared to
its peers, DHG Pharmaceutical JSC, Hatay
Pharmaceutical JSC and Imexpharm Pharmaceutical
JSC, which recorded debt to equity ratios of 0.07,
1.37 and 0.07 respectively.
___________________________________________________________________________________________
Vien Dong Pharmaceutical JSC - Company Capsule Page 1
Vien Dong Pharmaceutical JSC
_________________________________________________________________________________
TABLE OF CONTENTS
1 Business Analysis ................................................................................................................................... 5
1.1 Company Overview ................................................................................................................................................5
1.2 Major Products and Services .................................................................................................................................5
2 Analysis of Key Performance Indicators ............................................................................................... 6
2.1 Five Year Sna